0001209191-18-049890.txt : 20180906 0001209191-18-049890.hdr.sgml : 20180906 20180906171421 ACCESSION NUMBER: 0001209191-18-049890 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180906 DATE AS OF CHANGE: 20180906 EFFECTIVENESS DATE: 20180906 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Regenevida, Inc. CENTRAL INDEX KEY: 0001736337 IRS NUMBER: 000000000 STATE OF INCORPORATION: MN FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-320800 FILM NUMBER: 181058244 BUSINESS ADDRESS: STREET 1: 1246 UNIVERSITY AVENUE WEST STREET 2: SUITE 301 CITY: ST. PAUL STATE: MN ZIP: 55104 BUSINESS PHONE: 612-727-2000 MAIL ADDRESS: STREET 1: 1246 UNIVERSITY AVENUE WEST STREET 2: SUITE 301 CITY: ST. PAUL STATE: MN ZIP: 55104 D 1 primary_doc.xml X0708 D LIVE 0001736337 Regenevida, Inc. 1246 University Avenue West Suite 301 St. Paul MN MINNESOTA 55104 612-727-2000 MINNESOTA Avatar Genetics, Inc. None Corporation true 2013 Scott Fahrenkrug 1246 University Avenue West Suite 301 St. Paul MN MINNESOTA 55104 Executive Officer Director John F. Cameron 1246 University Avenue West Suite 301 St. Paul MN MINNESOTA 55104 Executive Officer Justin Zenanko 1246 University Avenue West Suite 301 St. Paul MN MINNESOTA 55104 Executive Officer Walter Low 1246 University Avenue West Suite 301 St. Paul MN MINNESOTA 55104 Executive Officer Biotechnology Decline to Disclose 06b false 2018-08-20 false true true true false 0 23551694 7358 23544336 Total Offering Amount includes $7,358 equity offering, plus warrants to purchase up to 2,943,042 shares of common stock at $8.00 per share, which may never be exercised. false 2 0 0 0 false Regenevida, Inc. /s/ Scott Fahrenkrug Scott Fahrenkrug Chief Executive Officer 2018-09-06